Anticancer agent 162

• Description :

  Anticancer agent 162 (compound 1d) is an effective anticancer theranostic agent. Anticancer agent 162 induces oncosis of Hela cells with lipophilicity and cytotoxicity selectivity[1].

• UNSPSC :

  12352005

• Target :

  Others

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/anticancer-agent-162.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=S([O-])(C(F)(F)F)=O.C1(N=C(C2=C(C3=[N]([Pt+2]45[C-]6=C(C7=[N]5C=CC=C7)C=CC=C6)C=CC=C38)[N]4=CC=C2)C8=N9)=C9C=CC=C1

• Molecular Formula :

  C30H18F3N5O3PtS

• Molecular Weight :

  780.64

• References & Citations :

  [1]Wang W, et al. A Series of Planar Phosphorescent Cyclometalated Platinum (II) Complexes as New Anticancer Theranostic Agents That Induce Oncosis. J Med Chem. 2023 Sep 28;66 (18) :13103-13115.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2761736-66-5]